vimarsana.com
Home
Live Updates
AskBio Announces First Patient Randomized in Phase 1 Trial o
AskBio Announces First Patient Randomized in Phase 1 Trial o
AskBio Announces First Patient Randomized in Phase 1 Trial of AB-1005 (AAV2-GDNF) Gene Therapy for Multiple System Atrophy-Parkinsonian Type (MSA-P)
Gene therapy AB-1005 being developed to locally increase glial cell line-derived neurotrophic factor (GDNF) levels in the brain for the treatment ...
Related Keywords
United States ,
Edinburgh ,
City Of ,
United Kingdom ,
Olmsted County ,
Minnesota ,
Research Triangle Park ,
North Carolina ,
Michigan ,
Scotland ,
Philipm Fortier ,
Nicolasm Phielipp ,
Krystof Bankiewicz ,
Brain Neurotherapy Bio Inc ,
Linkedin ,
European Study Group On Atypical Parkinsonisms ,
University Of California Irvine ,
Quest Research Institute ,
Bayer Ag ,
Asklepios Biopharmaceutical Inc ,
Drug Administration ,
Ohio State University Wexner Medical Center ,
Trademark Office ,
Asklepios Biopharmaceutical ,
Executive Director ,
California Irvine ,
Scientific Chair ,
United States Food ,
United States Patent ,
Multiple System ,
Accessed November ,
European Study Group ,
Auton Res ,